Upgrade to SI Premium - Free Trial

Merck (MRK) PT Raised to $86 at BofA Securities

October 29, 2021 8:24 AM

BofA Securities analyst Geoff Meacham raised the price target on Merck (NYSE: MRK) to $86.00 (from $85.00) while maintaining a Neutral rating.

Categories

Analyst PT Change

Next Articles